NCT04382859

Brief Summary

Our goal is to determine if liposomal bupivacaine compared to standard bupivacaine results in increased pain control and decreased narcotic pain medication use when used in TAP blocks prior to laparoscopic hysterectomies for benign indications.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 11, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

November 27, 2020

Status Verified

November 1, 2020

Enrollment Period

Same day

First QC Date

March 1, 2020

Last Update Submit

November 23, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Pain rating 1 hour post operation

    Participant-reported pain rating on a numeric 0 - 10 scale, with rating of 0 representing no pain and rating 10 representing worst pain

    1 hour post operation

  • Pain rating 2 hours post operation

    Participant-reported pain rating on a numeric 0 - 10 scale, with rating of 0 representing no pain and rating 10 representing worst pain

    2 hours post operation

  • Pain rating 4 hours post operation

    Participant-reported pain rating on a numeric 0 - 10 scale, with rating of 0 representing no pain and rating 10 representing worst pain

    4 hours post operation

  • Pain rating 72 hours post operation

    Participant-reported pain rating on a numeric 0 - 10 scale, with rating of 0 representing no pain and rating 10 representing worst pain

    72 hours post operation

Study Arms (2)

TAP block with liposomal bupivacaine

ACTIVE COMPARATOR

Active comparator

Procedure: Transversus abdominis plane (TAP) block with liposomal bupivacaine

TAP block with 0.25% bupivacaine

OTHER

Standard comparator

Procedure: Transversus abdominis plane (TAP) block with liposomal bupivacaine

Interventions

Transversus abdominis plane (TAP) blocks are safe and effective procedures for the provision of postoperative pain management following abdominal procedures (3) and have been widely used across specialties with reduction in postoperative pain and narcotic use (4-7).

TAP block with 0.25% bupivacaineTAP block with liposomal bupivacaine

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women undergoing non robotic assisted laparoscopic surgery for benign gynecologic conditions
  • English speaking

You may not qualify if:

  • Known current malignancy
  • Contraindication to medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bronson Methodist Hospital

Kalamazoo, Michigan, 49007, United States

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Dental Occlusion

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

DentistryDental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Officials

  • Melinda Abernethy, MD

    Western Michigan University Homer Stryker M.D. School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 1, 2020

First Posted

May 11, 2020

Study Start

December 1, 2020

Primary Completion

December 1, 2020

Study Completion

February 1, 2021

Last Updated

November 27, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations